ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Epigenetic Modifications Compromise Mitochondrial DNA Quality Control in the Development of Diabetic Retinopathy.

Mohammad, Ghulam; Radhakrishnan, Rakesh; Kowluru, Renu A
Invest Ophthalmol Vis Sci2019-9-3DOI: 10.1167/iovs.19-27602
3阅读
引用收藏
分享

摘要

Purpose: Diabetes causes dysfunction in the retinal mitochondria and increases base mismatches in their DNA (mtDNA). The enzyme responsible for repairing the base mismatches, MutL homolog 1 (Mlh1), is compromised. Diabetes also favors many epigenetic modifications and activates DNA methylation machinery, and Mlh1 has a CpG-rich promoter. Our aim is to identify the molecular mechanism responsible for impaired mtDNA mismatch repair in the pathogenesis of diabetic retinopathy. Methods: Human retinal endothelial cells, incubated in 20 mM glucose, were analyzed for mitochondrial localization of Mlh1 by an immunofluorescence technique, Mlh1 promoter DNA methylation by the methylated DNA capture method, and the binding of Dnmt1 and transcriptional factor Sp1 by chromatin immunoprecipitation. The results were confirmed in retinal microvessels from streptozotocin-induced diabetic mice, with or without Dnmt inhibitors, and from human donors with diabetic retinopathy. Results: Compared with cells in 5 mM glucose, high glucose decreased Mlh1 mitochondrial localization, and its promoter DNA was hypermethylated with increased Dnmt-1 binding and decreased Sp1 binding. Dnmt inhibitors attenuated Mlh1 promoter hypermethylation and prevented a decrease in its gene transcripts and an increase in mtDNA mismatches. The administration of Dnmt inhibitors in mice ameliorated a diabetes-induced increase in Mlh1 promoter hypermethylation and a decrease in its gene transcripts. Similar decreases in Mlh1 gene transcripts and its promoter DNA hypermethylation were observed in human donors. Conclusions: Thus, as a result of the epigenetic modifications of the Mlh1 promoter, its transcription is decreased, and decreased mitochondrial accumulation fails to repair mtDNA mismatches. Therapies targeted to halt DNA methylation have the potential to prevent/halt mtDNA damage and the development of diabetic retinopathy.

相关
加载中…
  • Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from high glucose-induced apoptosis.
    Zou Yu Ling; Luo Wen Bin; Xie Lin; Mao Xin Bang; Wu Chao; You Zhi Peng*Endocrine, 2018.
  • Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes
    Han Liyuan; Chen Chang; Lu Xingyu; Song Yanqun; Zhang Zhou; Zeng Chang; Chiu Rudyard; Li Li; Xu Miao; He Chuan; Zhang Wei; Duan ShiweiGenomics, 2021, 113(1P1).
  • Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications
    Geng, Xinqian; Li, Zheng; Yang, Ying*Frontiers in Endocrinology, 2022, 13: 907060.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Invest Ophthalmol Vis Sci
发表日期
2019-09-03
卷期
第 60 卷, 第 12 期
页码
3943-3951
DOI
10.1167/iovs.19-27602
成果收录
PUBMED

作者

  • M

    Mohammad, Ghulam (第一作者)

  • R

    Radhakrishnan, Rakesh

查看全部 3 位作者收起作者
  • K

    Kowluru, Renu A

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417